Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 60 /hr
Hire Dr. Leila R.
Iran
USD 60 /hr
I am Leila Rahbarnia, an assistant professor in medical biotechnology at Tabriz University of Medical Sciences.
Profile Summary
Subject Matter Expertise
Services
Writing
Medical Writing
Work Experience
Affiliated Assistant Professor
Tabriz University of Medical Sciences
August 2018 - Present
assistant professor
Research Center for Infectious Diseases and Tropical Medicine, Tabriz University of Medical Sciences
July 2017 - Present 
Education
PhD
Tabriz University of Medical Sciences Drug Applied Research Center
July 2012 - Present
Phd biotechnology
Tabriz University of Medical Science
September 2012 - January 2016
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Leila Rahbarnia, Samaneh Jahandar-Lashaki, Safar Farajnia, Aref Faraji-Barhagh, Zahra Hosseini, Nasim Bakhtiyari (2025). Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update . Molecular Biotechnology.
Leila Rahbarnia, Parisa Mansouri Rad, Azam Safary, Azizeh ShadiDizaji, Zahra Maani (2024). The Synthetic Antimicrobial Peptide Derived From Melittin Displays Low Toxicity and Anti-infectious Properties . Probiotics and Antimicrobial Proteins.
Leila Rahbarnia, Milad Tolouie, Safar Farajnia, Davoud Farajzadeh, Ali Rabbizadeh Saray (2024). Critical Point Mutations in the RBD of SARS-COV-2 Involved in Binding to ACE2 . Molecular Genetics, Microbiology and Virology.
Leila Rahbarnia, Safar Farajnia, Nazli Khajehnasiri, Habib Zarredar (2023). Correction to: Design of a hybrid peptide derived from melittin and CXCL14 –C17: a molecular dynamics simulation study . Biologia.
Leila Rahbarnia, Zahra Maani, Safar Farajnia, Elaheh Zadeh Hosseingholi, Nazli Khajehnasiri, Parisa Mansouri (2023). Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction . Journal of Molecular Structure.
Maani, Z., Farajnia, S., Rahbarnia, L., Hosseingholi, E.Z., Khajehnasiri, N., Mansouri, P.(2023). Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction . Journal of Molecular Structure. 1272.
Shadman, Z., Ghasemali, S., Farajnia, S., Mortazavi, M., Biabangard, A., Khalili, S., Rahbarnia, L.(2023). In silico Validation of Pseudomonas aeruginosa Exotoxin A Domain I Interaction with the Novel Human scFv Antibody . Infectious Disorders - Drug Targets. 23. (5). p. 31-37.
Shanehbandi, D., Asadi, M., Seyedrezazadeh, E., Zafari, V., Shekari, N., Akbari, M., Rahbarnia, L., Zarredar, H.(2023). MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications . Current Molecular Medicine. 23. (7). p. 648-667.
Wunrow, H.Y., Bender, R.G., Vongpradith, A., Sirota, S.B., Swetschinski, L.R., Novotney, A., Gray, A.P., Ikuta, K.S., Sharara, F., Wool, E.E., et al.(2023). Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 . The Lancet Neurology. 22. (8). p. 685-711.
Nabizadeh, S., Rahbarnia, L., Nowrozi, J., Farajnia, S., Hosseini, F.(2023). Rational design of hybrid peptide with high antimicrobial property derived from Melittin and Lasioglossin . Journal of Biomolecular Structure and Dynamics.
Sheikhzadeh, B.H., Rahbarnia, L., Dehnad, A., Naghili, B., Saffarian, P.(2023). The high cross-transmission in methicillin resistant Staphylococcus aureus between healthy and patient communities . Iranian Journal of Microbiology. 15. (3). p. 408-413.
Farajnia, S., Rahbarnia, L., Khajehnasiri, N., Zarredar, H.(2023). Correction to: Design of a hybrid peptide derived from melittin and CXCL14 –C17: a molecular dynamics simulation study (Biologia, (2022), 77, 8, (2269-2280), 10.1007/s11756-022-01067-x) . Biologia. 78. (10). p. 3001.
Rad, P.M., Rahbarnia, L., Safary, A., ShadiDizaji, A., Maani, Z.(2023). The Synthetic Antimicrobial Peptide Derived From Melittin Displays Low Toxicity and Anti-infectious Properties . Probiotics and Antimicrobial Proteins.
Leila Rahbarnia, Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Azam Safary, Habib Zarredar, Amir Baghbanzadeh, Behrooz Naghili, Behzad Baradaran (2022). Correction to: Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 . Infection.
Leila Rahbarnia, Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Amir-Hossein Olfati, Azam Safary (2022). Bio-nano scale modifications of melittin for improving therapeutic efficacy . Expert Opinion on Biological Therapy.
Leila Rahbarnia, Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Azam Safary (2022). Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection . Infection.
Leila Rahbarnia, Safar Farajnia, Nazli Khajehnasiri, Habib Zarredar (2022). Design of a hybrid peptide derived from Melittin and CXCL14 –C17: A molecular dynamics simulation study . Biologia.
Akbarzadeh-Khiavi, M., Torabi, M., Rahbarnia, L., Safary, A.(2022). Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection . Infection. 50. (2). p. 295-308.
Farajnia, S., Rahbarnia, L., Khajehnasiri, N., Zarredar, H.(2022). Design of a hybrid peptide derived from Melittin and CXCL14 –C17: A molecular dynamics simulation study . Biologia. 77. (8). p. 2269-2280.
Lotfi, F., Shojaie, M., Rahbarnia, L., Dehnad, A., Naghili, B., Lotfi, H.(2022). Molecular characterization and genetic diversity of multidrug- and extensively drug-resistant A. baumannii clinical isolates . Gene Reports. 26.
Ghasemali, S., Farajnia, S., Barzegar, A., Rahmati, M., Negahdari, B., Rahbarnia, L., Yousefi-Nodeh, H.(2022). Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics . Anti-Cancer Agents in Medicinal Chemistry. 22. (10). p. 2026-2035.
Farajnia, S., Lotfi, F., Dehnad, A., Shojaie, M., Raisi, R., Rahbarnia, L., Bazmani, A., Naghili, B., Shiry, S.(2022). The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units . Iranian Journal of Microbiology. 14. (3). p. 319-327.
Ikuta, K.S., Swetschinski, L.R., Aguilar, G.R., Sharara, F., Mestrovic, T., Gray, A.P., Weaver, N.D., Wool, E.E., Han, C., Hayoon, A.G., et al.(2022). Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 . The Lancet. 400. (10369). p. 2221-2248.
Lotfi, F., Akbarzadeh-Khiavi, M., Lotfi, Z., Rahbarnia, L., Safary, A., Zarredar, H., Baghbanzadeh, A., Naghili, B., Baradaran, B.(2022). Correction to: Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 (Infection, (2021), 49, 6, (1133-1147), 10.1007/s15010-021-01644-3) . Infection. 50. (4). p. 1051.
Akbarzadeh-Khiavi, M., Torabi, M., Olfati, A.-H., Rahbarnia, L., Safary, A.(2022). Bio-nano scale modifications of melittin for improving therapeutic efficacy . Expert Opinion on Biological Therapy. 22. (7). p. 895-909.
Leila Rahbarnia, Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Azam Safary, Habib Zarredar, Amir Baghbanzadeh, Behrooz Naghili, Behzad Baradaran (2021). Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 . Infection.
Leila Rahbarnia, Maryam Dashtiahangar, Safar Farajnia, Arash Salmaninejad, Arezoo Gowhari Shabgah, Samaneh Ghasemali(2021). Anti-cancer Immunotoxins, Challenges, and Approaches . Current Pharmaceutical Design. 27. (7). p. 932--941. Bentham Science Publishers Ltd.
Dashtiahangar, M., Rahbarnia, L., Farajnia, S., Salmaninejad, A., Shabgah, A.G., Ghasemali, S.(2021). Anti-cancer immunotoxins, challenges, and approaches . Current Pharmaceutical Design. 27. (7). p. 932-941.
Rahbarnia, L., Farajnia, S., Naghili, B., Saeedi, N.(2021). Comparative evaluation of nested polymerase chain reaction for rapid diagnosis of human brucellosis . Archives of Razi Institute. 76. (2). p. 203-211.
Bahadori, A., Gökmen, T.G., Köksal, F., Tumgor, G., Agin, M., Sadighi, A., Ziaee, M., Rahbarnia, L.(2021). High prevalence of clarithromycin resistant Helicobacter pylori in Turkish children with gastric disorders . Gene Reports. 24.
Shadman, Z., Farajnia, S., Pazhang, M., Tohidkia, M., Rahbarnia, L., Najavand, S., Toraby, S.(2021). Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa . BMC Infectious Diseases. 21. (1).
Aftabi, Y., Ansarin, K., Shanehbandi, D., Khalili, M., Seyedrezazadeh, E., Rahbarnia, L., Asadi, M., Amiri-Sadeghan, A., Zafari, V., Eyvazi, S., et al.(2021). Long non-coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis . IUBMB Life. 73. (2). p. 307-327.
Saadati, M., Rahbarnia, L., Farajnia, S., Naghili, B., Mohammadzadeh, R.(2021). The prevalence of biofilm encoding genes in multidrug-resistant Acinetobacter baumannii isolates . Gene Reports. 23.
Lotfi, F., Akbarzadeh-Khiavi, M., Lotfi, Z., Rahbarnia, L., Safary, A., Zarredar, H., Baghbanzadeh, A., Naghili, B., Baradaran, B.(2021). Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 . Infection. 49. (6). p. 1133-1147.
Leila Rahbarnia, Alireza Dehnad, Mohammad Hossein Ghaffari Agdam, Behrooz Naghili, Parvaneh Saffarian(2020). Detection of hemolysine genes in methicillin-resistant S. aureus isolates obtained from a healthy population in north-west of Iran . Gene Reports. 21. p. 100874. Elsevier {BV}
Leila Rahbarnia, Safar Farajnia, Hajar Khaneshi, Hadi Farajnia, Behrooz Naghili, Asghar Tanomand(2020). Detection of blaOXA-23 and blaNDM-1 carbapenemase among clinical isolates of A. baumannii in Tabriz, north-west of Iran . Gene Reports. 18. p. 100555. Elsevier {BV}
Rahbarnia, L., Farajnia, S., Khaneshi, H., Farajnia, H., Naghili, B., Tanomand, A.(2020). Detection of blaOXA-23 and blaNDM-1 carbapenemase among clinical isolates of A. baumannii in Tabriz, north-west of Iran . Gene Reports. 18.
Nazari, A., Farajnia, S., Zahri, S., Bagherlou, N., Tanoumand, A., Rahbarnia, L.(2020). Cytoplasmic chaperones enhance soluble expression of anti-egfr huscfv in escherichia coli . Iranian Journal of Biotechnology. 18. (2). p. 67-74.
Ghasemali, S., Farajnia, S., Barzegar, A., Rahmati-Yamchi, M., Baghban, R., Rahbarnia, L., Nodeh, H.R.Y.(2020). New developments in anti-angiogenic therapy of cancer, review and update . Anti-Cancer Agents in Medicinal Chemistry. 21. (1). p. 3-19.
Dehnad, A., Agdam, M.H.G., Rahbarnia, L., Naghili, B., Saffarian, P.(2020). Detection of hemolysine genes in methicillin-resistant S. aureus isolates obtained from a healthy population in north-west of Iran . Gene Reports. 21.
Leila Rahbarnia, Fatemeh Ravanbakhsh Ghavghani, Behrooz Naghili, Alireza Dehnad, Ahad Bazmani, Mojtaba Varshochi, Mohammad Hossein Ghaffari Agdam(2019). Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran . BMC Research Notes. 12. (1). Springer Science and Business Media {LLC}
Leila Rahbarnia, Vahideh Ahmadzadeh, Safar Farajnia, Roghayyeh Baghban, Habib Zarredar(2019). CRISPR‐Cas system: Toward a more efficient technology for genome editing and beyond . Journal of Cellular Biochemistry. 120. (10). p. 16379--16392. Wiley
Leila Rahbarnia, Safar Farajnia, Behrooz Naghili, Vahideh Ahmadzadeh, Kamal Veisi, Roghayyeh Baghban, Sayna Toraby(2019). Current trends in targeted therapy for drug-resistant infections . Applied Microbiology and Biotechnology. 103. (20). p. 8301--8314. Springer Science and Business Media {LLC}
Rahbarnia, L., Farajnia, S., Naghili, B., Ahmadzadeh, V., Veisi, K., Baghban, R., Toraby, S.(2019). Current trends in targeted therapy for drug-resistant infections . Applied Microbiology and Biotechnology. 103. (20). p. 8301-8314.
Ahrabi, S.Z., Rahbarnia, L., Dehnad, A., Naghili, B., Agdam, M.H.G., Nazari, A.(2019). Incidence of oxacillin-susceptible meca-positive staphylococcus aureus (OS-MRSA) isolates and TSST-1 virulence factor among high school students in tabriz, Northwest of Iran . Archives of Clinical Infectious Diseases. 14. (4).
Baghban, R., Farajnia, S., Rajabibazl, M., Ghasemi, Y., Mafi, A.A., Hoseinpoor, R., Rahbarnia, L., Aria, M.(2019). Yeast Expression Systems: Overview and Recent Advances . Molecular Biotechnology. 61. (5). p. 365-384.
Ahmadzadeh, V., Farajnia, S., Baghban, R., Rahbarnia, L., Zarredar, H.(2019). CRISPR-Cas system: Toward a more efficient technology for genome editing and beyond . Journal of Cellular Biochemistry. 120. (10). p. 16379-16392.
Ghavghani, F.R., Rahbarnia, L., Naghili, B., Dehnad, A., Bazmani, A., Varshochi, M., Ghaffari Agdam, M.H.(2019). Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran . BMC Research Notes. 12. (1).
Dariushnejad, H., Farajnia, S., Zargami, N., Khosroshahi, S.A., Rahbarnia, L.(2018). Dsbc chaperone mediated soluble expression of human TNF-α in E. coli . Minerva Biotecnologica. 30. (1). p. 14-21.
Akbari, B., Farajnia, S., Zarghami, N., Mahdieh, N., Rahmati, M., Khosroshahi, S.A., Barzegar, A., Rahbarnia, L.(2017). Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A . Anti-Cancer Drugs. 28. (3). p. 263-270.
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Veisi, K., Khosroshahi, S.A., Tanomand, A.(2017). Development of a novel human scFv against EGFR L2 domain by phage display technology . Current Pharmaceutical Design. 23. (13). p. 2009-2014.
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Veisi, K., Ahmadzadeh, V., Akbari, B.(2017). Evolution of phage display technology: from discovery to application . Journal of Drug Targeting. 25. (3). p. 216-224.
Akbari, B., Farajnia, S., Ahdi Khosroshahi, S., Safari, F., Yousefi, M., Dariushnejad, H., Rahbarnia, L.(2017). Immunotoxins in cancer therapy: Review and update . International Reviews of Immunology. 36. (4). p. 207-219.
Leila Rahbarnia, Safar Farajnia, Hossein Babaei, Jafar Majidi, Kamal Veisi, Asghar Tanomand, Bahman Akbari(2016). Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology . Biologicals. 44. (6). p. 567--573. Elsevier {BV}
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Veisi, K., Tanomand, A., Akbari, B.(2016). Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology . Biologicals. 44. (6). p. 567-573.
Akbari, B., Farajnia, S., Zarghami, N., Mahdieh, N., Rahmati, M., Khosroshahi, S.A., Rahbarnia, L.(2016). Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR) . Protein Expression and Purification. 127. p. 8-15.
Ahdi Khosroshahi, S., Farajnia, S., Ghiamirad, M., Tanomand, A., Veisi, K., Rahbarnia, L., Akbari, B.(2016). Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR) . Protein Expression and Purification. 120. p. 59-64.
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Akbari, B., Khosroshahi, S.A.(2016). Development of a novel human single chain antibody against EGFRvIII antigen by phage display technology . Advanced Pharmaceutical Bulletin. 6. (4). p. 563-571.
Rahbarnia, L., Farajnia, S., Babaei, H., Majidi, J., Dariushnejad, H., Hosseini, M.K.(2016). Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers . Immunology Letters. 180. p. 31-38.
Jalalypour, F., Farajnia, S., Mahmoudi, F., Baradaran, B., Farajzadeh, D., Majidi, J., Rahbarnia, L.(2014). Cloning and expression of the variable regions of anti-EGFR monoclonal antibody in E. coli for production of a single chain antibody . Iranian Journal of Biotechnology. 12. (2).
Farajnia, S., Ahmadzadeh, V., Tanomand, A., Veisi, K., Khosroshahi, S.A., Rahbarnia, L.(2014). Development trends for generation of single-chain antibody fragments . Immunopharmacology and Immunotoxicology. 36. (5). p. 297-308.
Farajnia, S., Peerayeh, S.N., Tanomand, A., Majidi, J., Goudarzi, G., Naghili, B., Rahbarnia, L.(2014). Protective efficacy of recombinant exotoxin A — flagellin fusion protein against Pseudomonas aeruginosa infection . Canadian Journal of Microbiology. 61. (1). p. 60-64.
Rahbarnia, L., Farajnia, S., Naghili, B.(2012). Application of DsbA signal peptide for soluble expression of Leishmania infantum P4 Nuclease in E. coli . Asian Journal of Animal and Veterinary Advances. 7. (4). p. 326-333.
Pooshaneh, S., Farajnia, S., Soleimani Dorjag, M., Rahbarnia, L., Ansarin, Kh., Sohrabi, N., Peymani, A.(2012). Prevalence of extended-spectrum β-lactamase class A among Acinetobacter baumannii isolates from patients of Imam Reza hospital, Tabriz . Pharmaceutical Sciences. 17. (4). p. 225-232.
Farajnia, S., Rahbarnia, L., Maleki Zanjani, B., Alimohammadian, M.H., Abdoli Oskoee, S., Beh-Pajooh, A., Saeedi, N., Montazer Saheb, S.(2011). Molecular cloning and characterization of P4 nuclease from Leishmania infantum . Enzyme Research. 2011. (1).
Application of DsbA Signal Peptide for Soluble Expression of Leishmania infantum P4 Nuclease in E. coli. Asian Journal of Animal and Veterinary Advances.
Cloning and Expression of the Variable Regions of Anti-EGFR Monoclonal Antibody in E. coli for Production of a Single Chain Antibody. Iranian Journal of Biotechnology.
Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aerugi. Anti-cancer drugs.
Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR). Protein expression and purification.
Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR). Protein expression and purification.
Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology. Advanced pharmaceutical bulletin.
Development of a Novel Human scFv Against EGFR L2 Domain by Phage Display Technology. Current pharmaceutical design.
Development trends for generation of single-chain antibody fragments. Immunopharmacology and immunotoxicology.
Evolution of phage display technology: from discovery to application. Journal of drug targeting.
Immunotoxins in cancer therapy: Review and update. International Reviews of Immunology.
Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology. Biologicals.
Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers. Immunology letters.
Molecular cloning and characterization of P4 nuclease from Leishmania infantum. Enzyme research.
Protective efficacy of recombinant exotoxin A-flagellin fusion 1 protein against Pseudomonas aeruginosa infection. Canadian journal of microbiology.
Seroprevalence of Helicobacter pylori infection in patients suffering from gastric symptoms in the Northwest of Iran. African Journal of Microbiology Research.
Tongue carcinoma&58; case series and demographic analysis. Journal of Analytical Research in Clinical Medicine.
OTHER
Leila Rahbarnia, Alireza Dehnad, Rana Khosravi Rad, Behrooz Naghili, Aysan Golipor(2020). The Prevalence of ACME-arcA and PVL Genes Among Staphylococcus Aureus Isolates in a Student Population from North-West of Iran . Research Square
Dehnad, A., Rad, R.K., Rahbarnia, L., Naghili, B., Golipor, A.(2020). The Prevalence of ACME-arcA and PVL Genes Among Staphylococcus Aureus Isolates in a Student Population from North-West of Iran . Research Square.
leila rahbarnia, Safar Farajnia, Behrooz Naghili, Nazli Saeedi(2019). Comparative evaluation of nested PCR for diagnosis of human brucellosis . Research Square
Rahbarnia, L., Farajnia, S., Naghili, B., Saeedi, N.(2019). Comparative evaluation of nested PCR for diagnosis of human brucellosis . Research Square.
CONFERENCE POSTER
Isolation of human SCFV antibody against EGFR L2 domain by screening of human SCFV phage library. 1st Tabriz International Life Science Conference and 12th Iran Biophysical.
Ratings and Comments
Total Projects Awarded:
Comments: